If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

Share Price is delayed by 15 minutes
Get Live Data
241.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (4.255%)
Market Cap: £141.62m
TUNE Live PriceLast checked at - London Stock Exchange

Intraday Focusrite Share Chart

Director Share Dealings

2 Jul 2026 07:01

RNS Number : 7758K
Focusrite PLC
02 July 2026
 

Focusrite plc

 

("the Company" or "the Group")

 

Focusrite plc Discretionary Directors Bonus (Bonus)

Director Share Dealings

 

Focusrite plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 30 June 2026 it awarded ordinary shares of 0.1p each in the capital of the Company ("Shares") to Tim Carroll, Group CEO of the Company and Sally McKone, Group CFO of the Company (each Persons Discharging Managerial Responsibilities ("PDMRs")), as listed below.

The Shares were awarded to the PDMRs as part of the Company's annual bonus arrangements for the final 6 months of the Company's transitional 18 month financial year ended 28 February 2026. Each PDMR elected to convert a portion of their annual bonus into Shares, and in return received an award of further Shares on a 1:1 basis.

 

Neither PDMR may ordinarily sell, transfer, assign or dispose of the Shares for a period of two years.

 

The award of the shares was settled in part by the transfer of ordinary shares and in part with a cash payment equal to the market value of the ordinary shares to meet the awardee's liability to income tax and employee national insurance arising on award of the bonus shares.

 

Awardee

Number of Shares Awarded

Number of Shares Transferred to Awardee

Number of Shares Representing Awardee's Tax and NI Liability

Tim Carroll

36,070

19,117

16,953

Sally McKone

35,651

18,895

16,756

 

 

Following the award:

Mr. Carroll's beneficial holding is 156,054 Ordinary Shares in the Company representing 0.26% of the total number of shares in the Company; and

Ms McKone's beneficial holding is 101,414 Ordinary Shares in the Company representing 0.17% of the total number of shares in the Company.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Tim Carroll

 

2

Reason for the notification

a)

Position/status

 Group Chief Executive Officer

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

Legal Entity Identifier

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Acquisition of shares pursuant to Focusrite plc's bonus arrangements for the final 6 months of the Company's transitional 18 month financial year ended 28 February 2026

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

Nil

19,117

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

 

e)

Date of the transaction

30 June 2026

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Sally McKone

 

2

Reason for the notification

a)

Position/status

 Group Chief Financial Officer

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

Legal Entity Identifier

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Acquisition of shares pursuant to Focusrite plc's bonus arrangements for the final 6 months of the Company's transitional 18 month financial year ended 28 February 2026

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

Nil

18,895

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

 

e)

Date of the transaction

30 June 2026

f)

Place of the transaction

Outside a trading venue

 

-ends-

 

Enquiries

 

Focusrite plc

+44 (0) 1494 462246

Tim Carroll (CEO) / Sally McKone (CFO)

 

Investec Bank plc (Nominated Adviser and Joint Broker)

+44 (0) 20 7597 5970

David Flin / Nick Prowting / James Smith

 

Rosewood (Financial PR)

+44 (0) 20 7653 8702

John West / Llewellyn Angus / Lily Pearce

 

Notes to Editors

 

Focusrite plc is a global audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and musicians, its solutions facilitate the high-quality production of recorded and live sound. The Focusrite Group trades under eleven established brands: Focusrite, Novation, ADAM Audio, Martin Audio, Optimal Audio, Linea Research Sequential, Oberheim, Sonnox, OutBoard and TiMax.

 

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries.

 

The Group operates through two divisions: Content Creation and Audio Reproduction.

 

Within its Content Creation business, Focusrite offers audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation products are used in the creation of electronic music, from synthesizers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Sonnox is a leading designer of innovative, high-quality, award-winning audio processing software plug-ins for professional audio engineers. Sequential designs and manufactures high end analogue synthesizers under the Sequential and Oberheim brands.

 

The Audio Reproduction division provides high-quality, professional-grade solutions for both live sound and permanent installations. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. TiMax specialises in innovative immersive audio and show control technologies. OutBoard manufactures and sells industry standard rigging control products for live events, together with enterprise-level safety test, preparation and quality management for global rental companies and venues. Linea designs, develops, manufactures and sells innovative professional audio equipment globally.

 

The Company has offices in four continents and a global customer base with a distribution network covering approximately 240 territories.

 

Focusrite plc is traded on the AIM market, London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGUGDRCUGDGLD
Date   Source Headline
2nd Jul 20267:01 amRNSDirector Share Dealings
2nd Jul 20267:00 amRNSDirectors' Dealings
30th Jun 202610:26 amRNSDirector/PDMR Shareholding
30th Jun 202610:16 amRNSTR-1
29th Jun 20267:00 amRNSFinal Results
27th May 20267:00 amRNSNotice of Results
5th May 20264:25 pmRNSTR-1
8th Apr 20263:56 pmRNSTR-1
19th Mar 20267:00 amRNSTrading Update: Trading in-line with expectations
2nd Mar 20267:00 amRNSBoard Changes
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:19 amRNSTransfer of shares to Trust
24th Dec 20259:19 amRNSTransfer of shares to Trust
18th Nov 202512:38 pmRNSDirector Share Dealings
4th Nov 20257:00 amRNSInterim Results
14th Oct 20257:00 amRNSNotice of Results
16th Sep 20257:00 amRNSTrading Update
7th May 20253:25 pmRNSTR-1
30th Apr 20253:41 pmRNSDividend Timetable Correction
29th Apr 20257:00 amRNSInterim Results
16th Apr 20252:38 pmRNSGrant of Share Options to PDMRs
11th Apr 20258:50 amRNSTR-1
8th Apr 20251:43 pmRNSTR-1
8th Apr 20257:00 amRNSTR-1
8th Apr 20257:00 amRNSTR-1
3rd Apr 20257:00 amRNSNotice of Interim Results
26th Mar 20253:16 pmRNSTR-1
20th Mar 20257:00 amRNSTrading Update
19th Mar 20258:13 amRNSTR-1
4th Mar 20252:46 pmRNSTR-1
31st Jan 202512:29 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement and Trading Update
11th Dec 20247:00 amRNSTR-1
5th Dec 20243:38 pmRNSDirector Share Dealings
5th Dec 20243:37 pmRNSGrant of Share Options to PDMRs
5th Dec 20247:00 amRNSTR1
27th Nov 20247:00 amRNSFinal Results for the Year Ended 31 Aug 2024
30th Oct 20247:00 amRNSNotice: Final Results, Change of Year End, Auditor
28th Aug 20247:00 amRNSTrading Statement
1st Aug 20247:00 amRNSTR-1
15th Jul 20244:17 pmRNSTR-1
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.